Proteome and phosphoproteome profiling of nonsmall cell lung cancer cells treated by TRAIL

ABSTRACT: tumor necrosis factor-related apoptosis-inducing liagand is one of the promising cancer therapeutic, however, many tumors have developed different degrees of drug resistance during TRAIL treatment. the mechanism by which is unvlear, and here we reasoned that systematic proteomic and phosphoproteomic analysis of TRAIL signaling could dissect its mechanisms and provide a basis for developing therapeutics.

ORGANISM(S): Homo Sapiens

SUBMITTER: Hao Yang  

PROVIDER: PXD034338 | iProX | Mon Jun 06 00:00:00 BST 2022

REPOSITORIES: iProX